Report cover image

Rx/Reimbursement Adult Incontinence in Denmark

Publisher Euromonitor International
Published Mar 10, 2025
Length 19 Pages
SKU # EP19864022

Description

Value sales of RX/reimbursement adult incontinence grew in 2024 in Denmark, supported by the ageing population. It is estimated that around 80% of reimbursement recipients are aged 65 and older, a group that is expanding as life expectancy increases. The ageing population, coupled with rising obesity rates, underpins the recorded growth for RX/reimbursement adult incontinence in 2024, due to the strong link between older age, obesity, and incontinence.

Euromonitor International's Rx/Reimbursement adult incontinence in Denmark report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2020-2024, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2029 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Rx/Reimbursement adult incontinence market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

19 Pages
Rx/Reimbursement Adult Incontinence in Denmark
Euromonitor International
March 2025
List Of Contents And Tables
RX/REIMBURSEMENT ADULT INCONTINENCE IN DENMARK
KEY DATA FINDINGS
2024 DEVELOPMENTS
The ageing population supports ongoing retail value growth in 2024
Essity leads the competitive landscape, offering its established Tena brand
Distribution is via online orders or in-person collection at pharmacies
PROSPECTS AND OPPORTUNITIES
Retail adult incontinence is set to record a value uplift as acceptance widens
Innovation is expected to focus on sustainability, aligning with societal concerns
Assessments may become more stringent across the forecast period
CATEGORY DATA
Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2019-2024
Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2019-2024
Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2024-2029
Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2024-2029
TISSUE AND HYGIENE IN DENMARK
EXECUTIVE SUMMARY
Tissue and hygiene in 2024: The big picture
2024 key trends
Competitive landscape
Retail developments
What next for tissue and hygiene?
MARKET INDICATORS
Table 5 Birth Rates 2019-2024
Table 6 Infant Population 2019-2024
Table 7 Female Population by Age 2019-2024
Table 8 Total Population by Age 2019-2024
Table 9 Households 2019-2024
Table 10 Forecast Infant Population 2024-2029
Table 11 Forecast Female Population by Age 2024-2029
Table 12 Forecast Total Population by Age 2024-2029
Table 13 Forecast Households 2024-2029
MARKET DATA
Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2019-2024
Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2019-2024
Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2020-2024
Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2021-2024
Table 18 Penetration of Private Label in Retail Tissue and Hygiene by Category: % Value 2019-2024
Table 19 Distribution of Retail Tissue and Hygiene by Format: % Value 2019-2024
Table 20 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2024
Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2024-2029
Table 22 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2024-2029
DISCLAIMER
SOURCES
Summary 1 Research Sources

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us